Regeneron Announces Presentation at the 25th Annual Credit Suisse Healthcare Conference

TARRYTOWN, N.Y., Oct. 21, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 25th Annual Credit Suisse Healthcare Conference at 10:00 a.m. ET on Tuesday, November 8, 2016.

The session may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, atopic dermatitis, pain, oncology, and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-25th-annual-credit-suisse-healthcare-conference-300348597.html

SOURCE Regeneron Pharmaceuticals, Inc.